本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Replimune Group Inc.

8.77
+0.77009.63%
盘后9.200.4350+4.96%19:32 EDT
成交量:134.94万
成交额:1,199.81万
市值:6.75亿
市盈率:-2.96
高:9.33
开:7.86
低:7.83
收:8.00
数据加载中...

公司资料

公司名字:
Replimune Group Inc.
交易所:
NASDAQ
成立时间:
2015
员工人数:
331
公司地址:
500 Unicorn Park Drive,Suite 303,Woburn,Massachusetts,United States
邮编:
01801
电话:
传真:
- -
简介:
Replimune Group, Inc.于2015年在特拉华州注册成立。该公司是一家临床阶段的生物技术公司,致力于应用他们在溶瘤免疫治疗领域的领先专业技术,改变癌症患者的生活。使用该公司专有的Immulytic平台来设计和开发旨在最大限度激活免疫系统对抗癌症的候选产品。

董事

名称
职位
Philip Astley Sparke
Chief Executive Officer and Director
Robert Coffin
President, Chief Research and Development Officer and Director
Christy Oliger
Director
Dieter Weinand
Director
Hyam Levitsky
Director
Joseph Slattery
Director
Kapil Dhingra
Director
Paolo Pucci
Director
Veleka Peeples Dyer
Director

股东

名称
职位
Philip Astley Sparke
Chief Executive Officer and Director
Colin Love
Chief Operating Officer
Andrew Schwendenman
Chief Accounting Officer and Treasurer
Christopher Sarchi
Chief Commercial Officer
Konstantinos Xynos
Chief Medical Officer
Pamela Esposito
Chief Business Officer
Robert Coffin
President, Chief Research and Development Officer and Director
Sushil Patel
Chief Strategy Officer
Tanya Lewis
Chief Development Operations Officer